lobbying_activities: 1200625
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1200625 | 8dd17a6d-a424-44da-9f3e-ff6b7ab2edcd | Q4 | COMPASS CONSULTING GROUP, LLC | 295031 | AMYLIN PHARMACEUTICALS, INC. | 2011 | fourth_quarter | PHA | General FDA, pharmaceutical, and Medicare issues. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-01-20T08:44:08.983000-05:00 |